Officially endorsed by the European Hypertension Society, the 1st Gulf Hypertension Conference is the NEW addition in the Arab Health Congress 2015. The aim of the conference is to provide the most updated clinical and scientific data in the field of hypertension (HTN). Over two-action packed days most aspects of hypertension management will be discussed. A group of highly specialised physicians will gather to present and discuss the latest recommendations, guidelines and debates in the field. The conference will elaborate on the extent of the disease and its impact in the region. It will provide physicians, as well as regional health agencies, with recent advancements in the field as well as improving hypertension management, ultimately reflecting in the delivery of better patient care and outcomes. Key topics Epidemiology of HTN Updates on antihypertensive medications Renal denervation and baroreceptor stimulation therapies in treating hypertension Chronic kidney disease and diabetic nephropathy updates Hypertension in pregnancy and transplant populations

1. Key topics:
• Epidemiology of hypertension
• Updates on antihypertensive medications
• Renal denervation and baroreceptor
stimulation therapies in treating
hypertension
• Chronic kidney disease and diabetic
nephropathy updates
• Hypertension in pregnancy and transplant
populations
NEW
1st Gulf Hypertension
Conference
26-27 January 2015
Dubai International Convention & Exhibition Centre
Benefits of attending:
• Review the latest hypertension guidelines
• Review diagnostic and management strategies for
patients with hypertension
• Discuss cardiovascular risk factors in hypertensive patients
• Review treatment of hypertension in special populations
• Review new advances in hypertension
• Clinical case scenarios with clinical implications and
management points
Part of
26-29 January 2015
Dubai International Convention & Exhibition Centre
Book and
pay before
4 December 2014
and save up to
US$80
Provided by: Leading congress supporter: Organised by:
Supporting bodies: In association with:
Tel: +971 4 336 7334 | ahcongress@informa.com | www.ahcongress.com

2. Dear Healthcare Professional,
On behalf of the Scientific and Organising Committees, it gives us great pleasure to invite you to participate in the
1st Gulf Hypertension Conference, taking place from 26-27 January 2015 at Dubai International Convention & Exhibition Centre.
Provided by the Cleveland Clinic, this new conference is part of the Arab Health Congress, the world’s largest multi-track medical
congress. Furthermore, it is one of a handful of events in the region to offer Continuing Medical Education (CME) to attending
medical professionals via its scientific exchange.
The aim of this conference is to provide a review and update of topics pertinent to clinical practice in hypertension. Over two
days, regional and international experts will address diagnosis and management strategies, as well as analyse recent advances
in hypertension. The conference will also elaborate on the extent of the disease and its impact in our region. This will be a great
opportunity for physicians, allied healthcare practitioners, and regional health agencies to obtain updated evidence-based
information that can be incorporated into clinical practice, in collaboration to plan Public Health interventions that can address the
rising prevalence of hypertension in the region.
The conference will include highlights from the latest 2014 Annual European Hypertension meeting in Athens, and will also discuss
updated European, American, and regional hypertension guidelines.
The conference will provide a unique platform to interact with internationally recognised experts in the field of hypertension and
cardiovascular risk factors. The programme has been designed to allow adequate time for discussion and interaction with speakers
and panelists, and it will also include case scenarios from clinical experience.
We look forward to welcoming you to the 1st Gulf Hypertension Conference in January.
Yours sincerely,
Dr J. Al Said
Conference Chair
1st Gulf Hypertension Conference
Dr George Thomas
Activity Director
1st Gulf Hypertension Conference
P.S. Contact the Arab Health Congress registration team directly to learn more about group discounts and early bird rates.
Call +971 4 336 7334 or email ahcongress@informa.com
Who should attend
• General Practitioners
• Emergency Physicians
• Cardiologists
• Nephrologists
• Anaesthesiologists
• Family Physicians
• Intensive Care Physicians
Accreditation statement
The Cleveland Clinic Foundation Center for Continuing Education
is accredited by the Accreditation Council for Continuing Medical
Education to provide continuing medical education for physicians.
The Cleveland Clinic Foundation Center for Continuing Education
designates this live activity for a maximum of 15.25 AMA PRA Category 1
CreditsTM. Physicians should claim only the credit commensurate with the
extent of their participation in the activity.
Participants claiming CME credit from this activity may submit the credit
hours to the American Osteopathic Association for Category 2 credit.
You may also be interested
in the following conferences:
3rd Middle East
Diabetes
Conference
26 - 27 January 2015
7th Middle East
Gastroenterology
Conference
28 - 29 January 2015
8th Middle East
Paediatrics
Conference
26 - 28 January 2015
5th Respiratory,
Critical Care and Sleep
Disorders Conference
28 - 29 January 2015
8th Middle East
Update in Urology
Conference
26 - 27 January 2015
The Arab Health Congress 2015 FEATURES 18 conferences
For more information on these and other conferences, visit www.ahcongress.com

3. DAY One: Monday, 26 January 2015
08:15 Opening remarks by the Chair
Dr Jafar Al Said, Chair of Internal Medicine, Consultant
Nephrology and Internal Medicine, Bahrain Specialist
Hospital, Manama, Bahrain
SESSION 1: GUIDELINES AND REGIONAL
EPIDEMIOLOGY
Moderators: Dr Habib Tareif, Consultant Cardiothoracic
Surgeon, Bahrain Defence Force Hospital, Ar-Rifaa, Bahrain
Mona Alrukhaimi, Professor of Medicine, President, EMAN, ISH
Chair Middle East, Chair, KDIGO Implementation Task Force
Middle East & Africa, Consultant Physician and Nephrology,
Dubai, UAE
08:30 Epidemiology of hypertension in the region
Dr Jafar Al Said, Chair of Internal Medicine, Consultant
Nephrology and Internal Medicine, Bahrain Specialist
Hospital, Manama, Bahrain
09:00 Hypertension management in view of the ESH 2013
guidelines
Dr Giuseppe Mancia, Professor Emeritus, University
of Milano-Bicocca; President, ESH Foundation;
Chairman, ESH Educational Board, Milan, Italy
09:30 Updated United States hypertension guidelines
– ‘JNC 8’ panel and ASH/ISH recommendations:
Strengths, limitations, and controversies
Dr George Thomas, Nephrology and Hypertension,
Glickman Urological and Kidney Institute, Cleveland
Clinic, Cleveland, Ohio, USA
10:00 The new 2014 Egyptian hypertension guidelines
Dr Mohamed Mohsen Ibrahim, Professor of
Cardiology, Cairo University; President, Egyptian
Hypertension Society, Cairo, Egypt
10:30 COFFEE BREAK
SESSION 2: HIGHLIGHTS FROM THE
ATHENS 2014 ANNUAL ESH MEETING
Moderators: Dr Giuseppe Mancia, Professor Emeritus, University
of Milano-Bicocca; President, ESH Foundation; Chairman, ESH
Educational Board, Milan, Italy
Dr Mohamed Mohsen Ibrahim, Professor of Cardiology, Cairo
University; President, Egyptian Hypertension Society, Cairo, Egypt
11:00 Highlights of Athens ESH 2014 meeting
Dr Athanasios Manolis, Director Cardiology
Department, Asklepeion Hospital, Athens, Greece;
Clinical Professor of Medicine, Emory University,
Atlanta, GA, USA; Assistant Professor of
Hypertension, Boston University, Boston
Massachusetts, USA
11:30 Atrial fibrillation and HTN: Is there any relation?
Dr Athanasios Manolis, Director Cardiology
Department, Asklepeion Hospital, Athens, Greece;
Clinical Professor of Medicine, Emory University,
Atlanta, Georgia, USA; Assistant Professor
of Hypertension, Boston University, Boston
Massachusetts, USA
12:00 Resistant hypertension: Approach to diagnosis and
management
Dr George Thomas, Nephrology and Hypertension,
Glickman Urological and Kidney Institute, Cleveland
Clinic, Cleveland, Ohio, USA
12:30 PANEL DISCUSSION
Panelists: Speakers of session 2
13:00 LUNCH BREAK
SESSION 3: NEW ADVANCES IN
HYPERTENSION MANAGEMENT
Moderators: Dr Athanasios Manolis, Director Cardiology
Department, Asklepeion Hospital, Athens, Greece; Clinical
Professor of Medicine, Emory University Atlanta; Assistant
Professor of Hypertension, Boston University, Boston,
Massachusetts, USA
Dr Fuad Ziyadeh, Professor of Medicine and Chairman of
Department of Internal Medicine, American University of
Beirut, Beirut, Lebanon
14:00 Renal denervation therapy: Where do we currently
stand?
Dr George Thomas, Nephrology and Hypertension,
Glickman Urological and Kidney Institute, Cleveland
Clinic, Cleveland, Ohio, USA
14:30 Do fixed combined pills make a difference?
Dr Giuseppe Mancia, Professor Emeritus, University
of Milano-Bicocca; President, ESH Foundation,
Chairman, ESH Educational Board, Milan, Italy
15:00 Baroreflux stimulation: How could it help in
management of HTN?
Dr George Thomas, Nephrology and Hypertension,
Glickman Urological and Kidney Institute, Cleveland
Clinic, Cleveland, Ohio, USA
15:30 PANEL DISCUSSION
Panelists: Speakers of session 3
16:00 COFFEE BREAK
SESSION 4: KIDNEY DISEASE AS A
CARDIOVASCULAR RISK FACTOR
Moderators: Dr George Thomas, Nephrology and
Hypertension, Glickman Urological and Kidney Institute,
Cleveland Clinic, Cleveland, Ohio, USA
Dr Jafar Al Said, Chair of Internal Medicine, Consultant
Nephrology and Internal Medicine, Bahrain Specialist Hospital,
Manama, Bahrain
16:30 Chronic kidney disease as cardiovascular risk factor
Dr Fuad Ziyadeh, Professor of Medicine and Chairman
of Department of Internal Medicine, American
University of Beirut, Beirut, Lebanon
17:00 Hypertension management and target blood
pressure in patients with chronic kidney disease
Dr Yousef Boobes, Consultant Nephrologist, Head of
Nephrology Department, Tawam Hospital, Al Ain,
Abu Dhabi, UAE
17:30 Hypertension management in the organ transplant
population
Dr Mona Alrukhaimi, Professor of Medicine, President,
EMAN; ISH Chair Middle East, Chair, KDIGO
Implementation Task Force Middle East & Africa,
Consultant Physician and Nephrology, Dubai, UAE
18:00 PANEL DISCUSSION
Panelists: Speakers of session 4
18:30 END OF CONFERENCE DAY ONE

4. DAY two: Tuesday, 27 January 2015
08:15 Opening remarks by the Chair
Dr Jafar Al Said, Chair of Internal Medicine,
Consultant Nephrology and Internal Medicine,
Bahrain Specialist Hospital, Manama, Bahrain
SESSION 5: CARDIOVASCULAR RISK
FACTORS
Moderators: Dr Mohamed Mohsen Ibrahim, Professor
of Cardiology, Cairo University; President, Egyptian
Hypertension Society, Cairo, Egypt
Dr Bader A. Almustafa, Senior Consultant, Family Medicine
& Chronic CareClinical Hypertension Specialist General
Secretary, Saudi Hypertension Society, Riyadh, KSA
08:30 BP variability: A new management target
Dr Giuseppe Mancia, Professor Emeritus, University
of Milano-Bicocca; President, ESH Foundation;
Chairman, ESH Educational Board, Milan, Italy
09:00 Coronary artery disease in patients with
hypertension: Approach and management
Dr Haitham Amin, Consultant Cardiologist,
Mohammed Bin Khalifa Cardiac Center, BDF
Hospital, Ar-Rifaa, Bahrain
09:30 Update on diabetic nephropathy and its
management
Dr Fuad Ziyadeh, Professor of Medicine and
Chairman of Department of Internal Medicine,
American University of Beirut, Beirut, Lebanon
10:00 PANEL DISCUSSION
Panelists: Speakers of session 5
10:30 COFFEE BREAK
SESSION 6: BLOOD PRESSURE
MEDICATIONS
Moderators: Dr Yousef Boobes, Consultant Nephrologist,
Tawam Hospital, Al Ain, UAE
Dr Rashed Abdulla, Consultant Cardiologist, Salmaniya
Medical Complex, Manama, Bahrain
11:00 Beta-blockers: Where does the evidence lie?
Dr Athanasios Manolis, Director Cardiology
Department, Asklepeion Hospital, Athens, Greece;
Clinical Professor of Medicine, Emory University
Atlanta; Assistant Professor of Hypertension, Boston
University, Boston, Massachusetts, USA
11:30 ACE inhibitors: Recent updates and
recommendations
Dr Haitham Amin, Consultant Cardiologist,
Mohammed Bin Khalifa Cardiac Center, BDF
Hospital, Bahrain
12:00 Proteinuria and cardiovascular risk
Dr Jafar Al Said, Chair of Internal Medicine,
Consultant Nephrology and Internal Medicine,
Bahrain Specialist Hospital, Manama, Bahrain
12:30 PANEL DISCUSSION
Panelists: Speakers of session 6
13:00 LUNCH BREAK
SESSION 7: HYPERTENSION IN SPECIAL
POPULATIONS
Moderators: Dr Habib Tareif, Consultant Cardiothoracic
Surgeon, Bahrain Defence Force Hospital, Ar-Rifaa, Bahrain
Dr Yousef Boobes, Consultant Nephrologist, Tawam Hospital,
Al Ain, UAE
14:00 Hypertension in pregnancy
Dr Mona Alrukhaimi, Professor of Medicine, President,
EMAN; ISH Chair Middle East, Chair, KDIGO
Implementation Task Force Middle East & Africa,
Consultant Physician and Nephrology, Dubai, UAE
14:30 Blood pressure control in a cohort from
Bahrain
Dr Rashed Abdulla, Consultant Cardiologist,
Salmaniya Medical Complex, Manama, Bahrain
15:00 Hypertensive crisis
Dr Rashed Abdulla, Consultant Cardiologist,
Salmaniya Medical Complex, Manama, Bahrain
15:30 Strategies for blood pressure control in
stroke patients
Dr Waleed Sultan, Cardiology Specialist, Bahrain
Specialist Hospital, Manama, Bahrain
16:00 COFFEE BREAK
SESSION 8: HYPERTENSION REVIEW
Moderators: Dr Jafar Al Said, Chair of Internal Medicine,
Consultant Nephrology and Internal Medicine, Bahrain
Specialist Hospital, Manama, Bahrain
Dr George Thomas, Nephrology and Hypertension, Glickman
Urological and Kidney Institute, Cleveland Clinic, Cleveland,
Ohio, USA
16:30 Panel discussion: A comprehensive review of
hypertension from across the globe and Middle East
Panelists: Dr Giuseppe Mancia, Professor Emeritus,
University of Milano-Bicocca; President, ESH
Foundation; Chairman, ESH Educational Board,
Milan, Italy
Dr Mohamed Mohsen Ibrahim, Professor of
Cardiology, Cairo University; President, Egyptian
Hypertension Society, Cairo, Egypt
Dr Mona Alrukhaimi, Professor of Medicine,
President, EMAN, ISH Chair Middle East, Chair,
KDIGO implementation Task Force Middle East &
Africa, Consultant Physician and Nephrology,
Dubai, UAE
17:15 CLOSE OF CONFERENCE

5. Conference Chair:
Dr Jafar Al Said, Chair of Internal Medicine,
Consultant Nephrology and Internal Medicine,
Bahrain Specialist Hospital, Bahrain
Activity Director:
Dr George Thomas, Nephrology and
Hypertension, Glickman Urological and Kidney
Institute, Cleveland Clinic, Cleveland,
Ohio, USA
Co-activity Director:
Dr Robert Heyka, Chairman of Nephrology & Hypertension,
Glickman Urological and Kidney Institute, Cleveland Clinic,
Cleveland, Ohio, USA
Speaker faculty:
Dr Athanasios Manolis, Director Cardiology Department,
Asklepeion Hospital, Athens, Greece; Clinical Professor of Medicine,
Emory University Atlanta; Assistant Professor of Hypertension,
Boston University, Boston, Massachusetts, USA
Dr Bader A. Almustafa, Senior Consultant, Family Medicine & Chronic
CareClinical Hypertension Specialist General Secretary,
Saudi Hypertension Society, Riyadh, KSA
Dr Fuad Ziyadeh, Professor of Medicine and Chairman of Department
of Internal Medicine, American University of Beirut, Beirut, Lebanon
Dr Giuseppe Mancia, Professor Emeritus, University of Milano-
Bicocca; President, ESH Foundation; Chairman, ESH Educational
Board, Milan, Italy
Dr Habib Tareif, Consultant Cardiothoracic Surgeon, Bahrain
Defence Force Hospital, Ar-Rifaa, Bahrain
Dr Haitham Amin, Consultant Cardiologist, Bahrain Defence Force
Hospital, Ar-Rifaa, Bahrain
Dr Mohamed Mohsen Ibrahim; Professor of Cardiology, Cairo
University; President, Egyptian Hypertension Society, Cairo, Egypt
Dr Mona Alrukhaimi, Professor of Medicine, President, EMAN; ISH
Chair Middle East, Chair, KDIGO implementation Task Force Middle
East & Africa, Consultant Physician and Nephrology, Dubai, UAE
Dr Rashed Abdulla, Consultant Cardiologist, Salmaniya Medical
Complex, Manama, Bahrain
Dr Waleed Sultan, Cardiology Specialist, Bahrain Specialist Hospital,
Manama, Bahrain
Dr Yousef Boobes, Consultant Nephrologist, Tawam Hospital,
Al Ain, UAE
Faculty disclosure statement
The Cleveland Clinic Foundation Center for Continuing Education has implemented
a policy to comply with the current Accreditation Council for Continuing Medical
Education Standards for Commercial Support requiring resolution for all faculty conflicts
of interest. Faculty declaring a relevant interest will be identified in the activity syllabus.

6. You can register online at
www.ahcongress.com using your
priority booking code: HYP15CB
5 WAYS TO REGISTER:
+971 4 336 7334
+971 4 336 4021
ahcongress@informa.com
www.ahcongress.com
Informa Exhibitions,
P.O. Box 9428, Dubai, UAE
1st Gulf
Hypertension Conference
26-27 January 2015
Delegate booking form. Please complete and fax back to +971 4 336 4021
Conference Book and pay before Book and pay before Book and
1 day Hypertension Conference 720 200 825 225 900 250
2 days Hypertension Conference 1,100 300 1,265 345 1,380 380
Delegate details:
4 December 2014 21 January 2015 pay on-site
AED USD AED USD AED USD
Mr/Ms/Dr/Other: First Name: Surname:
Degree (eg. MD, PhD, DO, RN):
Speciality:
Job Title: Email:
Tel: Fax: Mobile:
Delegate 1
Mr/Ms/Dr/Other: First Name: Surname:
Degree (eg. MD, PhD, DO, RN):
Speciality:
Job Title: Email:
Tel: Fax: Mobile:
Delegate 2
Mr/Ms/Dr/Other: First Name: Surname:
Degree (eg. MD, PhD, DO, RN):
Speciality:
Job Title: Email:
Tel: Fax: Mobile:
Delegate 3
Company details:
Company/Hospital:
Address: Email:
Postcode: Country:
Tel: Fax:
No. of employees on your site:
1000+ 500-999 250-499 50-249 0-49
Nature of your company’s business:
YES, I would like to receive information
about future events & services via email
(Enter email address)
To assist us with future correspondence, please supply the following details:
Name of Department Head:
Department: Mobile: Email:
Name of Training Manager:
Department: Mobile: Email:
Name of Booking Contact (if different from above):
Department: Mobile: Email:
Dubai International Convention & Exhibition Centre
If you are attending only one of the two days, please indicate your chosen day below
26 January 2015 27 January 2015
Registration includes syllabus, lunches and refreshment breaks
Please tick (✓) if you would like to pay by:
Credit card Cash Cheque
Bank transfer Bank draft
A confirmation letter and invoice will be sent
upon receipt of your registration. Please note
that full payment must be received prior to the
event. Only those delegates whose fees have
been paid in full will be admitted to the event.
You can pay by company cheque in Dirhams or
US$. Please note that all US$ cheques and bank
drafts should be drawn on a New York bank and
an extra amount of US$6 per payment should
be added to cover bank clearing charges.
All payments should be in favour of Informa
Middle East Limited Dubai Branch.
Cheque payment made payable to Informa
Middle East Limited Dubai Branch and send
to P.O. Box 9428, Dubai, UAE
(Please note: Informa Middle East Limited
Dubai Branch will not cover any transfer
charges. Please add US$30 extra)
Cash payment can be made at the Informa
Exhibitions Floor 19, Sheikh Rashid Tower,
Dubai Trade Centre
Tel: +971 4 336 7334,
Office hours: Sunday – Thursday,
09:00 – 17:30
Travel and accommodation
Yes, please contact me to book travel
and accommodation
Cancellation
If you are unable to attend, a substitute
delegate will be welcome in your place. If this
is not suitable, a 50% service charge will be
payable. Registrations cancelled less than 14
days before the event will not be refunded.
Hotel and accommodation details
Please contact: Hospitality department
Tel: +971 4 407 2693
Fax: +971 4 407 2517
Email: hospitality@informa.com
Due to unforeseen circumstances, the
programme may change and Informa
Exhibitions reserves the right to alter the
venue and/or speakers.